Scar Treatment Market By Scar Type (Atrophic Scar, Hypertrophic and Keloid Scar, Contractures, Stretch Marks), By Product (Topical, Laser based treatment, Others), By End User (Hospitals, Clinics, Home Care): Global Opportunity Analysis and Industry Forecast, 2021-2031
Scar is a mark remaining on the skin after injured tissue has healed. Scars are known to produce deep structural changes inside the deep layers of skin. Scares are classified into atrophic scars, hypertrophic scars, contractures, stretch marks, and keloid scars. Scar treatment is carried out to improve or reduce appearance of scars. It also restores function and corrects skin changes (disfigurement) caused by an injury, wound, poor healing, or previous surgery. Scars can be treated with radiation, lasers treatment, polyurethane dressing, silicone gel, corticosteroid injections, cryosurgery, and bleomycin injections.
Rise in number of road accidents and burn incidences boosts growth of the market. Road accidents and burn cases are responsible for scar formation. For instance, according to the National Highway Traffic Safety Administration (NHTSA) of the U.S. Department of Transportation in 2020, 38,680 people died in motor vehicle traffic crashes. in addition, some accients requires surgical operation which further contributes in the growth of scar treatment market.
Furthermore, increase in demand for cosmetic surgeries to improve appearance and restore scar marks propel growth of the market. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS) survey, in 2020 around 10,129,528 cosmetic surgical procedures were carried worldwide.
Moreover, increase in R&D activities and novel product launches in the market by key players boost the market growth. For instance, in September, 2021, SkinCeuticals, a leading medical skincare brand, launched Advanced scar control gel, specifically formulated for different types of scars and ideal complement to post-procedure scar care for procedures such as Mohs surgery and scar revision surgery. Furthermore, rise in number of hospitals and improvements in healthcare infrastructure further contributes toward the market growth. However, high cost of scar treatment limits growth of the market.
The scar treatment market is segmented on the basis of scar type, product, end user, and region. By scar type, the market is divided into atrophic scars, hypertrophic & keloid scars, contractures, and stretch marks. By product, it is divided into topical, laser-based treatment, and others. By end user, it is divided into hospitals, clinics, and home care. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the scar treatment market analysis from 2021 to 2031 to identify the prevailing scar treatment market opportunity.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the scar treatment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global scar treatment market size.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global scar treatment market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Scar Type
Atrophic Scar
Hypertrophic and Keloid Scar
Contractures
Stretch Marks
By Product
Topical
Laser based treatment
Others
By End User
Hospitals
Clinics
Home Care
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Avita Medical Limited
Bausch Health Companies Inc.
Cynosure, Inc.
hra pharma
Mölnlycke Health Care AB
Polytech Health & Aesthetics GmbH
Sientra, Inc.
sisram inc
Smith and Nephew plc.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: SCAR TREATMENT MARKET, BY SCAR TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Atrophic Scar
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Hypertrophic and Keloid Scar
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Contractures
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.5 Stretch Marks
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
- CHAPTER 5: SCAR TREATMENT MARKET, BY PRODUCT
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Topical
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Laser based treatment
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Others
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: SCAR TREATMENT MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Clinics
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Home Care
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: SCAR TREATMENT MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Scar Type
- 7.2.3 North America Market size and forecast, by Product
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Scar Type
- 7.2.5.1.2 Market size and forecast, by Product
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Scar Type
- 7.2.5.2.2 Market size and forecast, by Product
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Scar Type
- 7.2.5.3.2 Market size and forecast, by Product
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Scar Type
- 7.3.3 Europe Market size and forecast, by Product
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Scar Type
- 7.3.5.1.2 Market size and forecast, by Product
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Scar Type
- 7.3.5.2.2 Market size and forecast, by Product
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 U.K.
- 7.3.5.3.1 Market size and forecast, by Scar Type
- 7.3.5.3.2 Market size and forecast, by Product
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Scar Type
- 7.3.5.4.2 Market size and forecast, by Product
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Scar Type
- 7.3.5.5.2 Market size and forecast, by Product
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Scar Type
- 7.3.5.6.2 Market size and forecast, by Product
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Scar Type
- 7.4.3 Asia-Pacific Market size and forecast, by Product
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Market size and forecast, by Scar Type
- 7.4.5.1.2 Market size and forecast, by Product
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 China
- 7.4.5.2.1 Market size and forecast, by Scar Type
- 7.4.5.2.2 Market size and forecast, by Product
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 Australia
- 7.4.5.3.1 Market size and forecast, by Scar Type
- 7.4.5.3.2 Market size and forecast, by Product
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 India
- 7.4.5.4.1 Market size and forecast, by Scar Type
- 7.4.5.4.2 Market size and forecast, by Product
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Scar Type
- 7.4.5.5.2 Market size and forecast, by Product
- 7.4.5.5.3 Market size and forecast, by End User
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Market size and forecast, by Scar Type
- 7.4.5.6.2 Market size and forecast, by Product
- 7.4.5.6.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Scar Type
- 7.5.3 LAMEA Market size and forecast, by Product
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Scar Type
- 7.5.5.1.2 Market size and forecast, by Product
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Scar Type
- 7.5.5.2.2 Market size and forecast, by Product
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Scar Type
- 7.5.5.3.2 Market size and forecast, by Product
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Scar Type
- 7.5.5.4.2 Market size and forecast, by Product
- 7.5.5.4.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Avita Medical Limited
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Bausch Health Companies Inc.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Cynosure, Inc.
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 hra pharma
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Mölnlycke Health Care AB
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Polytech Health & Aesthetics GmbH
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Sientra, Inc.
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 sisram inc
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Smith and Nephew plc.
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 2. SCAR TREATMENT MARKET REVENUE, FOR ATROPHIC SCAR, BY REGION , 2021-2031,($MILLION)
- TABLE 3. SCAR TREATMENT MARKET FOR ATROPHIC SCAR BY COUNTRY, 2021-2031,($MILLION)
- TABLE 4. SCAR TREATMENT MARKET REVENUE, FOR HYPERTROPHIC AND KELOID SCAR, BY REGION , 2021-2031,($MILLION)
- TABLE 5. SCAR TREATMENT MARKET FOR HYPERTROPHIC AND KELOID SCAR BY COUNTRY, 2021-2031,($MILLION)
- TABLE 6. SCAR TREATMENT MARKET REVENUE, FOR CONTRACTURES, BY REGION , 2021-2031,($MILLION)
- TABLE 7. SCAR TREATMENT MARKET FOR CONTRACTURES BY COUNTRY, 2021-2031,($MILLION)
- TABLE 8. SCAR TREATMENT MARKET REVENUE, FOR STRETCH MARKS, BY REGION , 2021-2031,($MILLION)
- TABLE 9. SCAR TREATMENT MARKET FOR STRETCH MARKS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 10. GLOBAL SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 11. SCAR TREATMENT MARKET REVENUE, FOR TOPICAL, BY REGION , 2021-2031,($MILLION)
- TABLE 12. SCAR TREATMENT MARKET FOR TOPICAL BY COUNTRY, 2021-2031,($MILLION)
- TABLE 13. SCAR TREATMENT MARKET REVENUE, FOR LASER BASED TREATMENT, BY REGION , 2021-2031,($MILLION)
- TABLE 14. SCAR TREATMENT MARKET FOR LASER BASED TREATMENT BY COUNTRY, 2021-2031,($MILLION)
- TABLE 15. SCAR TREATMENT MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
- TABLE 16. SCAR TREATMENT MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 17. GLOBAL SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 18. SCAR TREATMENT MARKET REVENUE, FOR HOSPITALS, BY REGION , 2021-2031,($MILLION)
- TABLE 19. SCAR TREATMENT MARKET FOR HOSPITALS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 20. SCAR TREATMENT MARKET REVENUE, FOR CLINICS, BY REGION , 2021-2031,($MILLION)
- TABLE 21. SCAR TREATMENT MARKET FOR CLINICS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 22. SCAR TREATMENT MARKET REVENUE, FOR HOME CARE, BY REGION , 2021-2031,($MILLION)
- TABLE 23. SCAR TREATMENT MARKET FOR HOME CARE BY COUNTRY, 2021-2031,($MILLION)
- TABLE 24. SCAR TREATMENT MARKET, BY REGION, 2021-2031,($MILLION)
- TABLE 25. NORTH AMERICA SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 26. NORTH AMERICA SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 27. NORTH AMERICA SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 28. NORTH AMERICA SCAR TREATMENT MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 29. U.S. SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 30. U.S. SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 31. U.S. SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 32. CANADA SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 33. CANADA SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 34. CANADA SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 35. MEXICO SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 36. MEXICO SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 37. MEXICO SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 38. EUROPE SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 39. EUROPE SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 40. EUROPE SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 41. EUROPE SCAR TREATMENT MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 42. GERMANY SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 43. GERMANY SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 44. GERMANY SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 45. FRANCE SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 46. FRANCE SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 47. FRANCE SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 48. U.K. SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 49. U.K. SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 50. U.K. SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 51. ITALY SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 52. ITALY SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 53. ITALY SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 54. SPAIN SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 55. SPAIN SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 56. SPAIN SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 57. REST OF EUROPE SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 58. REST OF EUROPE SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 59. REST OF EUROPE SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 60. ASIA-PACIFIC SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 61. ASIA-PACIFIC SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 62. ASIA-PACIFIC SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 63. ASIA-PACIFIC SCAR TREATMENT MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 64. JAPAN SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 65. JAPAN SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 66. JAPAN SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 67. CHINA SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 68. CHINA SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 69. CHINA SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 70. AUSTRALIA SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 71. AUSTRALIA SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 72. AUSTRALIA SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 73. INDIA SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 74. INDIA SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 75. INDIA SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 76. SOUTH KOREA SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 77. SOUTH KOREA SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 78. SOUTH KOREA SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 79. REST OF ASIA-PACIFIC SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 80. REST OF ASIA-PACIFIC SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 81. REST OF ASIA-PACIFIC SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 82. LAMEA SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 83. LAMEA SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 84. LAMEA SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 85. LAMEA SCAR TREATMENT MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 86. BRAZIL SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 87. BRAZIL SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 88. BRAZIL SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 89. SAUDI ARABIA SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 90. SAUDI ARABIA SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 91. SAUDI ARABIA SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 92. SOUTH AFRICA SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 93. SOUTH AFRICA SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 94. SOUTH AFRICA SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 95. REST OF LAMEA SCAR TREATMENT MARKET, BY SCAR TYPE, 2021-2031,($MILLION)
- TABLE 96. REST OF LAMEA SCAR TREATMENT MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 97. REST OF LAMEA SCAR TREATMENT MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 98.AVITA MEDICAL LIMITED: COMPANY SNAPSHOT
- TABLE 99.AVITA MEDICAL LIMITED: OPERATING SEGMENTS
- TABLE 100.AVITA MEDICAL LIMITED: PRODUCT PORTFOLIO
- TABLE 101.AVITA MEDICAL LIMITED: NET SALES,
- TABLE 102.AVITA MEDICAL LIMITED: KEY STRATERGIES
- TABLE 103.BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT
- TABLE 104.BAUSCH HEALTH COMPANIES INC.: OPERATING SEGMENTS
- TABLE 105.BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO
- TABLE 106.BAUSCH HEALTH COMPANIES INC.: NET SALES,
- TABLE 107.BAUSCH HEALTH COMPANIES INC.: KEY STRATERGIES
- TABLE 108.CYNOSURE, INC.: COMPANY SNAPSHOT
- TABLE 109.CYNOSURE, INC.: OPERATING SEGMENTS
- TABLE 110.CYNOSURE, INC.: PRODUCT PORTFOLIO
- TABLE 111.CYNOSURE, INC.: NET SALES,
- TABLE 112.CYNOSURE, INC.: KEY STRATERGIES
- TABLE 113.HRA PHARMA: COMPANY SNAPSHOT
- TABLE 114.HRA PHARMA: OPERATING SEGMENTS
- TABLE 115.HRA PHARMA: PRODUCT PORTFOLIO
- TABLE 116.HRA PHARMA: NET SALES,
- TABLE 117.HRA PHARMA: KEY STRATERGIES
- TABLE 118.MÖLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT
- TABLE 119.MÖLNLYCKE HEALTH CARE AB: OPERATING SEGMENTS
- TABLE 120.MÖLNLYCKE HEALTH CARE AB: PRODUCT PORTFOLIO
- TABLE 121.MÖLNLYCKE HEALTH CARE AB: NET SALES,
- TABLE 122.MÖLNLYCKE HEALTH CARE AB: KEY STRATERGIES
- TABLE 123.POLYTECH HEALTH & AESTHETICS GMBH: COMPANY SNAPSHOT
- TABLE 124.POLYTECH HEALTH & AESTHETICS GMBH: OPERATING SEGMENTS
- TABLE 125.POLYTECH HEALTH & AESTHETICS GMBH: PRODUCT PORTFOLIO
- TABLE 126.POLYTECH HEALTH & AESTHETICS GMBH: NET SALES,
- TABLE 127.POLYTECH HEALTH & AESTHETICS GMBH: KEY STRATERGIES
- TABLE 128.SIENTRA, INC.: COMPANY SNAPSHOT
- TABLE 129.SIENTRA, INC.: OPERATING SEGMENTS
- TABLE 130.SIENTRA, INC.: PRODUCT PORTFOLIO
- TABLE 131.SIENTRA, INC.: NET SALES,
- TABLE 132.SIENTRA, INC.: KEY STRATERGIES
- TABLE 133.SISRAM INC: COMPANY SNAPSHOT
- TABLE 134.SISRAM INC: OPERATING SEGMENTS
- TABLE 135.SISRAM INC: PRODUCT PORTFOLIO
- TABLE 136.SISRAM INC: NET SALES,
- TABLE 137.SISRAM INC: KEY STRATERGIES
- TABLE 138.SMITH AND NEPHEW PLC.: COMPANY SNAPSHOT
- TABLE 139.SMITH AND NEPHEW PLC.: OPERATING SEGMENTS
- TABLE 140.SMITH AND NEPHEW PLC.: PRODUCT PORTFOLIO
- TABLE 141.SMITH AND NEPHEW PLC.: NET SALES,
- TABLE 142.SMITH AND NEPHEW PLC.: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.SCAR TREATMENT MARKET SEGMENTATION
- FIGURE 2.SCAR TREATMENT MARKET,2021-2031
- FIGURE 3.SCAR TREATMENT MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.SCAR TREATMENT MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.SCAR TREATMENT MARKET,BY SCAR TYPE,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ATROPHIC SCAR SCAR TREATMENT MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF HYPERTROPHIC AND KELOID SCAR SCAR TREATMENT MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF CONTRACTURES SCAR TREATMENT MARKET,2021-2031(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF STRETCH MARKS SCAR TREATMENT MARKET,2021-2031(%)
- FIGURE 17.SCAR TREATMENT MARKET,BY PRODUCT,2021(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF TOPICAL SCAR TREATMENT MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF LASER BASED TREATMENT SCAR TREATMENT MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS SCAR TREATMENT MARKET,2021-2031(%)
- FIGURE 21.SCAR TREATMENT MARKET,BY END USER,2021(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HOSPITALS SCAR TREATMENT MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CLINICS SCAR TREATMENT MARKET,2021-2031(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF HOME CARE SCAR TREATMENT MARKET,2021-2031(%)
- FIGURE 25.SCAR TREATMENT MARKET BY REGION,2021
- FIGURE 26.U.S. SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 27.CANADA SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 28.MEXICO SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 29.GERMANY SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 30.FRANCE SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 31.U.K. SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 32.ITALY SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 33.SPAIN SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 34.REST OF EUROPE SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 35.JAPAN SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 36.CHINA SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 37.AUSTRALIA SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 38.INDIA SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 39.SOUTH KOREA SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 40.REST OF ASIA-PACIFIC SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 41.BRAZIL SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 42.SAUDI ARABIA SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 43.SOUTH AFRICA SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 44.REST OF LAMEA SCAR TREATMENT MARKET,2021-2031($MILLION)
- FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 49.COMPETITIVE DASHBOARD
- FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 51.AVITA MEDICAL LIMITED.: NET SALES ,($MILLION)
- FIGURE 52.BAUSCH HEALTH COMPANIES INC..: NET SALES ,($MILLION)
- FIGURE 53.CYNOSURE, INC..: NET SALES ,($MILLION)
- FIGURE 54.HRA PHARMA.: NET SALES ,($MILLION)
- FIGURE 55.MÖLNLYCKE HEALTH CARE AB.: NET SALES ,($MILLION)
- FIGURE 56.POLYTECH HEALTH & AESTHETICS GMBH.: NET SALES ,($MILLION)
- FIGURE 57.SIENTRA, INC..: NET SALES ,($MILLION)
- FIGURE 58.SISRAM INC.: NET SALES ,($MILLION)
- FIGURE 59.SMITH AND NEPHEW PLC..: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook